15th QP Forum Pre-Conference Sesssion: Specific Requirements for IMPs

15th QP Forum Pre-Conference Sesssion: Specific Requirements for IMPs

Berlin, Germany

Course No 17526

 

Costs

Regular Fee: EUR 990,--

(All prices excl. VAT)

If you have any questions, please contact us:
Tel.: +49 (0)6221 / 84 44 0 E-Mail: info@gmp-compliance.org

Speakers

Dr. Susanne Ding, Boehringer Ingelheim, Germany
Patryk Jegorow, Takeda, Ireland
Niina Taylor, Pfizer, U.K.
Brenda Van Assche, Janssen Pharmaceutica NV, Belgium
other Speakers invited

Programme

  • New legislation impacting IMP QPs
  • Interactive sessions and case studies – decision making for IMP QPs
  • Phase appropriate GMP
  • IMP QP involvement in Compassionate Use, Named Patient Use and Early Access Programs
  • Q&A sessions

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK